title: Study design and rationale for the clinical outcomes of the STABILITY Trial (STabilization of Atherosclerotic plaque By Initiation of darapLadIb TherapY) comparing darapladib versus placebo in patients with coronary heart disease.
authors.affiliation: Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand. harveyw@adhb.govt.nz
authors.forename: Harvey
authors.initials: H
authors.lastname: White
authors.forename: Claes
authors.initials: C
authors.lastname: Held
authors.forename: Ralph
authors.initials: R
authors.lastname: Stewart
authors.forename: David
authors.initials: D
authors.lastname: Watson
authors.forename: Robert
authors.initials: R
authors.lastname: Harrington
authors.forename: Andrzej
authors.initials: A
authors.lastname: Budaj
authors.forename: Ph Gabriel
authors.initials: PG
authors.lastname: Steg
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Cannon
authors.forename: Susan
authors.initials: S
authors.lastname: Krug-Gourley
authors.forename: Janet
authors.initials: J
authors.lastname: Wittes
authors.forename: Trupti
authors.initials: T
authors.lastname: Trivedi
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Tarka
authors.forename: Lars
authors.initials: L
authors.lastname: Wallentin